Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on ...

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

Omada Health is poised to generate over 35% growth while approaching adjusted EBITDA breakeven, Needham analysts say.

Omada Health has released new data indicating that its GLP-1 companion program significantly enhances medication persistence for GLP-1 treatments, which are linked to increased weight loss. The ...

Omada Health, Inc. (NASDAQ:OMDA) closed its first day of trading at $23 per share on Friday, a 21% jump from the IPO price of $19 per share. On Thursday, Omada Health priced its initial public ...

Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% ...